Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Non-Current Liabilities (2016 - 2025)

Ptc Therapeutics has reported Other Non-Current Liabilities over the past 14 years, most recently at $13.7 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $13.7 million for Q4 2025, up 1613.0% from a year ago — trailing twelve months through Dec 2025 was $13.7 million (up 1613.0% YoY), and the annual figure for FY2025 was $13.7 million, up 1613.0%.
  • Other Non-Current Liabilities for Q4 2025 was $13.7 million at Ptc Therapeutics, up from $2.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PTCT hit a ceiling of $252.0 million in Q3 2021 and a floor of $77000.0 in Q3 2024.
  • Median Other Non-Current Liabilities over the past 5 years was $36.2 million (2024), compared with a mean of $95.1 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 99.94% in 2023 and later soared 25573.76% in 2024.
  • Ptc Therapeutics' Other Non-Current Liabilities stood at $239.9 million in 2021, then crashed by 31.64% to $164.0 million in 2022, then crashed by 99.91% to $141000.0 in 2023, then skyrocketed by 467.38% to $800000.0 in 2024, then surged by 1613.0% to $13.7 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $13.7 million (Q4 2025), $2.6 million (Q3 2025), and $7.8 million (Q2 2025) per Business Quant data.